Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neurology|July 27, 2001
Patterns of disease in concordant parent-child pairs with multiple sclerosisR Hupperts, S Broadley, A Mander, et al.
Molecular Immunology|December 3, 2014
Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosisE Peelen, J Damoiseaux, A-H Muris, et al.
Acta Neurologica Scandinavica|March 13, 2012
Fatigue and heat sensitivity in patients with multiple sclerosisY Bol, J Smolders, A Duits, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 10, 2012
Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteriaE Peelen, G Rijkers, A Meerveld-Eggink, et al.
Journal of Neuroimmunology|March 17, 2015
GM-CSF production by CD4+ T cells in MS patients: regulation by regulatory T cells and vitamin DE Peelen, A-H Muris, J Damoiseaux, et al.
Journal of Neuroimmunology|March 23, 2013
Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulatorsE Peelen, M Thewissen, S Knippenberg, et al.
Acta Neurologica Scandinavica|June 15, 2013
Higher levels of reported sun exposure, and not vitamin D status, are associated with less depressive symptoms and fatigue in multiple sclerosisS Knippenberg, J Damoiseaux, Y Bol, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2008
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosisN De Stefano, M Filippi, C Confavreux, et al.
European Journal of Neurology|March 27, 2015
BREMSO: a simple score to predict early the natural course of multiple sclerosisR Bergamaschi, C Montomoli, G Mallucci, et al.
European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.
Pageof 3